You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《即日市评》期结日恒指倒跌 渣打绩後软 石药弹半成
阿思达克 07-30 17:04
今日期指结算日,港股呈先升後回。美联储局昨晚宣布维持利率不变,符合市场预期。联储局公开市场委员会承诺将动用一切可用工具来支持经济,并将利率维持在接近零的水平,直至经济从疫情中恢复过来,执笔之时美汇指数升至93.5980,美股道指期货最新跌221点或0.8%,美股纳指期货最新下滑116点或1.1%。上证综指3,300点得而复失,全日反覆跌0.2%收3,286,内地创业板指收下滑0.9%,沪深两市成交额共1.09万亿人民币。

恒指今早高开96点後,曾升314点一度高见25,197点,午後市况转弱,尾市曾跌267点见24,616点,最终全日跌172点或0.7%,收24,710点;国指跌87点或0.9%,收10,097点;恒生科技指数升15点或0.2%,收7,100点。大市全日成交总额1,283.71亿元,沪、深港通南下交易录得净流入金额分别为28.82亿及33.46亿元人民币。

科技股走个别,腾讯(00700.HK)及中芯(00981.HK)股价各走低1.2%及1.4%,但美团(03690.HK)则升1%。部份猪肉股受捧,中粮肉食(01610.HK)抽高15.8%。

【恒指呈倒跌 石药扬半成】

石药(01093.HK)全日股价抽上5.1%收16.06元,成升幅最大蓝筹股。中金发表报告指,石药是国内第一梯队的龙头制药企业之一,具备优秀的研发、生产和销售能力,加上公司存量业务稳定,而创新药研发管线价值逐渐提升,重申「跑赢行业」评级,上调除权後目标价5%至21元。该行料2020-2023年之间公司将有13个创新药和高端制剂上市,予石药当前创新药管线300亿元的估值,认为公司资金充足,且和国内外多个研发平台和机构合作,研发管线有望进一步丰富。

新世界发展(00017.HK)股价上扬2.9%收37.65元。美银证券发表报告,调高对新世界发展投资评级,由「中性」升至「买入」,目标价由42元上调至45元。该行称,即使在新冠疫情爆发的高峰期,本港住宅用家需求仍然巩固,公司将出大围站物业项目,料可从相关项目收取共370亿元现金,加上出售非核心资产,有能力支持其稳定派息及减低现金流的压力。

【沽空率上升 渣打绩後软】

港股今日市宽转弱,主板股票的升跌比率为20比22(上日为26比18),恒指成份股今日18只股份上升,下跌股份30只,升跌比率为36比60(上日为68比28);大市日录沽空174.73亿元,占可沽空股份成1,012.86亿元的17.251%(上日为15.649%)。

渣打(02888.HK)半年业绩稍胜预期,午後股价曾倒升3.6%,最终收市跌1.9%。渣打中午公布中期业绩,法定表现下除税前溢利按年倒退33%至16.27亿美元,稍高於本网早前综合4间券商预测之介乎11.11亿美元至16.26亿美元。法定表现下纯利按年倒退29%至10.48亿美元,每股盈利25.8美仙。集团展望,下半年,收入无论是按半年还是按全年比较均可能会有所下降。支出通常在下半年会较高,但渣打的目标继续是将今年的支出控制在100亿美元以下。

摩根士丹利发表报告表示,渣打今年第二季基本除税前溢利录7.33亿美元,指其第二季业绩优於市场预期,收入按年下跌4%,此高於预期约5%,及受惠成本因素,渣打第二季拨备前经营利润(PPoP)亦高於市场同业预期25%。大摩指,渣打管理层料今年下半年收入将较上半年及去年同期呈回落,此符合该行预期,而拨备支出前景仍存不明朗因素,但应低於上半年,维持对渣打「与大市同步」评级及目标价46元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account